Our ******* ysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Turns out people will actually buy more deodorant, not just pay more for the same bottle. Unilever just proved it, and Wall Street liked the smell of that a lot more than the profit margin underneath it.
Unilever reported first-half revenue of €25.6 billion, powered by underlying sales growth of 4.8%, ahead of expectations and driven mostly by volume rather than price. Volumes rose 4.2% in the first half, with price increases filling in the rest.
The second quarter ran even hotter. Underlying sales grew 5.8%, beating ******* yst forecasts, while volumes jumped 5.5%, Unilever's strongest quarterly volume performance since 2010. Management upgraded full-year guidance to 4% to 6% underlying sales growth, up from the low end of that range, alongside roughly 3% volume growth expected for the year.
Beauty and wellbeing, personal care, and home care carried the quarter, with Dove, Vaseline, Rexona, Lynx, Cif, and Axe all benefiting from heavier marketing spend and a major World Cup push. Food was the weak link, volumes slipping slightly, which is exactly the division Unilever is already peeling off into a standalone business through its deal with McCormick.
#underlying #Growth #quarter
Turns out people will actually buy more deodorant, not just pay more for the same bottle. Unilever just proved it, and Wall Street liked the smell of that a lot more than the profit margin underneath it.
Unilever reported first-half revenue of €25.6 billion, powered by underlying sales growth of 4.8%, ahead of expectations and driven mostly by volume rather than price. Volumes rose 4.2% in the first half, with price increases filling in the rest.
The second quarter ran even hotter. Underlying sales grew 5.8%, beating ******* yst forecasts, while volumes jumped 5.5%, Unilever's strongest quarterly volume performance since 2010. Management upgraded full-year guidance to 4% to 6% underlying sales growth, up from the low end of that range, alongside roughly 3% volume growth expected for the year.
Beauty and wellbeing, personal care, and home care carried the quarter, with Dove, Vaseline, Rexona, Lynx, Cif, and Axe all benefiting from heavier marketing spend and a major World Cup push. Food was the weak link, volumes slipping slightly, which is exactly the division Unilever is already peeling off into a standalone business through its deal with McCormick.
#underlying #Growth #quarter
3 months ago